These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 2839387)

  • 1. Interaction of sulfonylureas with pancreatic beta-cells. A study with glyburide.
    Gorus FK; Schuit FC; In't Veld PA; Gepts W; Pipeleers DG
    Diabetes; 1988 Aug; 37(8):1090-5. PubMed ID: 2839387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glyburide and tolbutamide induce desensitization of insulin release in rat pancreatic islets by different mechanisms.
    Rabuazzo AM; Buscema M; Vinci C; Caltabiano V; Vetri M; Forte F; Vigneri R; Purrello F
    Endocrinology; 1992 Oct; 131(4):1815-20. PubMed ID: 1396327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased cytosolic calcium. A signal for sulfonylurea-stimulated insulin release from beta cells.
    Nelson TY; Gaines KL; Rajan AS; Berg M; Boyd AE
    J Biol Chem; 1987 Feb; 262(6):2608-12. PubMed ID: 3029089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets.
    Macchi IA; Zeytinoğlu FN
    Horm Metab Res; 1976 Mar; 8(2):92-6. PubMed ID: 177348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function.
    Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F
    Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glyburide priming of beta cells. Possible involvement of phosphoinositide hydrolysis.
    Zawalich WS
    Biochem Pharmacol; 1991 Mar; 41(5):807-13. PubMed ID: 1847815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclic AMP and insulin release.
    Grill V
    Acta Paediatr Scand Suppl; 1977; (270):41-7. PubMed ID: 210617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose modulates the amount, but not the kinetics, of insulin released by sulfonylureas.
    Gregorio F; Ambrosi F; Filipponi P; Cristallini S; Santeusanio F
    J Diabetes Complications; 1994; 8(4):204-12. PubMed ID: 7833495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of cyclic AMP in the control of insulin secretion (author's transl)].
    Cerasi E; Grill V
    MMW Munch Med Wochenschr; 1977 Sep; 119(38):1229-36. PubMed ID: 198651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin release by tolbutamide and glibenclamide. A comparative study on the perfused rat pancreas.
    Joost HG; Hasselblatt A
    Naunyn Schmiedebergs Arch Pharmacol; 1979 Apr; 306(3):185-8. PubMed ID: 112482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The metabolism of cyclic AMP and glucose in isolated islets from Acomys cahirinus.
    Grill V; Cerasi E
    Diabetologia; 1979 Jan; 16(1):47-50. PubMed ID: 216600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glibenclamide inhibits islet carnitine palmitoyltransferase 1 activity, leading to PKC-dependent insulin exocytosis.
    Lehtihet M; Welsh N; Berggren PO; Cook GA; Sjoholm A
    Am J Physiol Endocrinol Metab; 2003 Aug; 285(2):E438-46. PubMed ID: 12684219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of glucose/sulfonylurea interaction on release of insulin, glucagon, and somatostatin from isolated perfused rat pancreas.
    Efendić S; Enzmann F; Nylén A; Uvnäs-Wallensten K; Luft R
    Proc Natl Acad Sci U S A; 1979 Nov; 76(11):5901-4. PubMed ID: 118458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-secretion of amylin and insulin from cultured islet beta-cells: modulation by nutrient secretagogues, islet hormones and hypoglycemic agents.
    Moore CX; Cooper GJ
    Biochem Biophys Res Commun; 1991 Aug; 179(1):1-9. PubMed ID: 1679326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
    Zawalich WS
    Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permissive effect of glucose on the glucagon-induced accumulation of cAMP in isolated rat pancreatic islets.
    Schauder P; Arends J; Schindler B; Ebert R; Frerichs H
    Diabetologia; 1977 Apr; 13(2):171-5. PubMed ID: 192621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of tolbutamide on aminophylline-, 3,5-AMP-dibutyrate- or glucagon-induced insulin release from pancreatic islets after impairment of pyridine nucleotide metabolism caused by 6-aminonicotinamide (6-AN).
    Ammon HP
    Naunyn Schmiedebergs Arch Pharmacol; 1975; 290(2-3):251-64. PubMed ID: 241943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term actions of sulfonylureas on (pro-) insulin biosynthesis and secretion: I. Lack of evidence for a compensatory increase in (pro-) insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro.
    Schatz H; Steinle D; Pfeiffer EF
    Horm Metab Res; 1977 Nov; 9(6):457-65. PubMed ID: 412764
    [No Abstract]   [Full Text] [Related]  

  • 19. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
    Grill V; Cerasi E
    J Clin Invest; 1978 May; 61(5):1346-54. PubMed ID: 207736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulphonylurea effects on insulin secretion in islets desensitized to glucose.
    Zhou DB; Ipp E
    Pancreas; 1990 Sep; 5(5):528-32. PubMed ID: 2122445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.